Clinical Trials in New York State

Showing 5421-5440 of 17,167 trials

The Lily Device Trial

NCT06786078

The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemotherapy, when hair preservation is a Grade ≤1 graded by an independent healthcare professional on the Common Terminology Criteria for Adverse Events (CTCAE)? * What is the subject incidence of Grade 1 or above Adverse Device Events (ADE's)?

Chemotherapy Induced Alopecia

Luminate Medical, Inc.85 participantsStarted Dec 2024

Mullica Hill, New Jersey, United States • Vineland, New Jersey, United States • Binghamton, New York, United States +2 more locations

Active Not RecruitingPhase 386 miles

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

Metastatic Non Small Cell Lung CancerAdvanced Non Small Cell Lung Cancer

Mirati Therapeutics Inc.453 participantsStarted Feb 2021

Cerritos, California, United States • Duarte, California, United States • Glendale, California, United States +340 more locations

The Lily Device Trial

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Find Trials by Condition in New York State

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Novel Experimental COVID-19 Therapies Affecting Host Response

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

A Randomized Controlled Trial of Leg Length Discrepancy Techniques

The OPBC-07/microNAC Study

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Intermediate-Size Expanded Access Protocol (EAP) for LP352

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma

The Gilenya Pregnancy Registry

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer